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The Great Coronavirus Pandemic of 2020—7 Critical Lessons
Lawrence O. Gostin, JD
nations, Spain and the United Kingdom.
The coronavirus pandemic teaches that
leadership is crucial. Perhaps the single
greatest indicator of success in responding
to COVID-19 has been whether governments gain the public’s trust. Populationbased health behaviors—handwashing and
other aspects of personal hygiene, physical distancing, and face coverings—can significantly reduce community spread.

First, Build Resilient Health Systems
The most important element of pandemic
preparedness is a resilient health system to
rapidly detect, assess, report, and respond
to novel outbreaks. The International Health
Regulations, which govern pandemic response, require all countries to have core
health system capacities, including surveillance, laboratories, human resources, and
risk communication. Health systems also
need capacity to test for, diagnose, and treat
infectious diseases.
Although high-income countries have
robust health systems, they often lacked
sufficient capacity to treat large numbers
of patients with coronavirus disease 2019
(COVID-19) or to protect health workers
from infection. In the US, hospitals and
governors had to compete for access
to ventilators and personal protective
equipment. Resilient health systems
require surge capacity to cope with health
emergencies in the event hospitals
become overrun.

Second, Leadership and Public Trust
Are the Single Greatest Indicator
of Success
Although health systems are important,
COVID-19 demonstrated that even countries with strong capacities often performed badly. The Global Health Security
Index, for example, ranked the US first
in the world for pandemic preparedness.
Yet, as of August 12, the US had reported
more than 5 million cases, the most
COVID-19 cases and deaths globally—2 million more than Brazil, which was second,
and far ahead of the more than 300 000
cases in each of the 2 hardest hit European
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Third, Defend the Integrity of Science
and Public Health Agencies
Science has enabled societies to understand the virus, its modes of transmission,
and most effective public health interventions. Within weeks of reports of a cluster of
atypical pneumonia cases in Wuhan,
China, scientists had sequenced the virus.
Epidemiological studies subsequently
determined severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was transmitted person to person,
including by asymptomatic individuals.
Further research showed that personal
hygiene, physical distancing, and face coverings were effective nontherapeutic
interventions. Research laboratories rapidly developed viral and antibody testing
technologies. There is promising scientific
research into effective vaccines and therapeutics. Within 6 months, 6 vaccine
candidates were in phase 3 clinical trials.
Despite remarkable, albeit incomplete,
scientific discovery, populist political leaders have sown doubt about the value of
science and have undermined public
health agencies. In Brazil and the US, for
example, political leaders have publicly
recommended COVID-19 treatments that
their own agencies have not approved,

such as hydroxychloroquine. President
Trump publicly criticized US Centers for
Disease Control and Prevention guidelines
for reopening schools. If political leaders
fail to implement evidence-based policies
or to convey consistent messages based
on science, the pandemic response will
be suboptimal.

Fourth, Invest in Biomedical Research
and Development
The integrity of science is necessary but
insufficient. Governments must sustainably invest in biomedical research and
development, not just during a health crisis but also during interpandemic periods.
After the West Africa Ebola epidemic, the
Commission on a Global Health Risk
Framework for the Future recommended
an incremental increase of $1 billion per year
to accelerate research and development
for innovative medical technologies. Even
$1 billion annually is far too low given
the economic devastation of the pandemic, with the World Bank projecting a
5.2% contraction in global GDP in 2020.
A World Health Organization (WHO) initiative, the R&D Blueprint for COVID-19,
shows the vast undertaking needed to
develop safe and effective therapeutics
and vaccines.

Fifth, Focus on Equity: The Prevailing
Narrative of This Age
Even before the coronavirus pandemic,
social, economic, and health inequities
became the prevailing global narrative.
Yet, COVID-19 amplified long-standing
systemic inequalities, including access to
health care. SARS-CoV-2 infections and
COVID-19 deaths disproportionately affected
racial minorities including Black, Hispanic,
and Native American individuals. Many
lower-paid workers, such as those in grocery stores, meatpacking plants, and truck
drivers, were exposed to individuals with
SARS-CoV-2 infection.
Also, although many white-collar professionals could work remotely with a
secure income, lower-income US workers
lost their jobs, with many facing evictions.
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he world is experiencing a once-ina-life time pandemic , causing
untold human suffering and death,
unraveling of social relationships, and robbing individuals of livelihoods and countries of prosperity. The coronavirus pandemic has strained health systems,
revealed unconscionable inequalities, and
upended international institutions. Here
are 7 critical lessons.
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US unemployment rose from 3.8% in
Februar y to 13% in May. Infec tious
diseases should affect populations similarly, but COVID-19 demonstrated that
low-income people, those who are less
educated, and racial minorities are disproportionately affected. It is unsurprising
that the Black Lives Matter protests coincided with the COVID-19 pandemic. Populations everywhere are expressing anger
with enduring health, social, and economic injustices.

Sixth, Adopt Evidence-Based Laws:
Safeguard the Rule of Law
State laws have long authorized public
health powers to test, trace, isolate, and
quarantine. These traditional powers can be
expanded in declared emergencies. Public
health laws are narrow and measured, requiring individual assessments of risk. Yet,
the COVID-19 response has gone beyond
anything seen since the 1918-1919 influenza pandemic. It was previously unimaginable that the government could lockdown
an entire city the size of New York or
Los Angeles. Yet, in April, more than half of
all US residents were under stay-at-home orders. Mayors and governors closed down all
nonessential businesses. Currently, nearly
half the states have imposed interstate travel
restrictions requiring travelers to selfquarantine for 14 days.
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These sweeping powers have not
been definitively tested. The US Supreme
Court has ruled on COVID-19–related cases
in relation to voting and religious freedom,
but it has not yet opined on the libertylimiting regulations imposed during the
COVID-19 response. Responding to
expansions of political power in countries like
Russia, Turkey, and Hungary, the United
Nations launched a Rule of Law project on
COVID-19. Emergency health powers
should be based on evidence and used
only when there are no less restrictive
alternatives. Usurpation of power under
the pretext of a health crisis threatens to
erode democratic freedoms, which can
endure even after the crisis ends.

Seventh, Fund and Support Robust
Global Institutions: We Are in This
Together
A once-in-a-lifetime threat that all the
world shares in common should bring
people and nations together. Yet the
COVID-19 pandemic has frayed international relations. In the midst of a historic
pandemic, 2 superpowers—China and the
US—blamed one another, even at the World
Health Assembly. In July, President Trump
notified the UN General Secretary the US
would withdraw from the WHO.
Yet, there are also hopeful signs of international cooperation. Public and private part-

ners joined with the WHO to launch the
Access to COVID-19 Tools (ACT) Accelerator,
a global collaboration to accelerate research
and development, production, and equitable access to COVID-19 tests, treatments,
and vaccines. COVAX—a partnership between Gavi, the Coalition for Epidemic Preparedness Innovations, and the WHO—is the
vaccine arm of ACT, designed to facilitate
the discovery of COVID-19 vaccines and guarantee fair and equitable global access.
Governments and international institutions have clear choices on how best to respond to COVID-19 and to prepare for future pandemics. Choosing science, the rule
of law, and equity as core values would be
transformational. Building universal health
systems would not only prepare countries
for epidemic response, it would also vastly
improve the health and well-being for all
people, across the full spectrum of health
threats faced by humankind.
Author Affiliation: Georgetown University Law
Center, Washington, DC.
Corresponding Author: Lawrence O. Gostin, JD,
Georgetown University Law Center, 600 New
Jersey Ave NW, McDonough 568, Washington, DC
20001 (gostin@law.georgetown.edu).
Conflict of Interest Disclosures: None reported.
Note: Source references are available through
embedded hyperlinks in the article text online.
Previous Publication: This article was previously
published in JAMA Health Forum at
jamahealthforum.com.

(Reprinted) JAMA November 10, 2020 Volume 324, Number 18

© 2020 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by a Georgetown University Medical Center User on 11/13/2020

1817

